Article ID Journal Published Year Pages File Type
3848399 American Journal of Kidney Diseases 2013 12 Pages PDF
Abstract
Rasburicase is effective in reducing serum uric acid levels in adults with TLS but at a significant cost, and evidence currently is lacking in adults to report whether rasburicase use improves clinical outcomes compared with other alternatives. Until new evidence is available, use of rasburicase may be limited to adult patients with a high risk of TLS.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , ,